Celemics, Inc. (KOSDAQ:331920)
12,850
0.00 (0.00%)
At close: Apr 3, 2026
Celemics Market Cap
Celemics has a market cap or net worth of 104.91 billion as of April 2, 2026. Its market cap has increased by 311.86% in one year.
Market Cap
104.91B
Enterprise Value
99.37B
Revenue
5.77B
Ranking
n/a
PE Ratio
n/a
Stock Price
12,850.00
Market Cap Chart
Since August 21, 2020, Celemics's market cap has decreased from 200.32B to 104.91B, a decrease of -47.63%. That is a compound annual growth rate of -10.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 104.91B | 373.30% |
| Dec 30, 2025 | 22.17B | -17.10% |
| Dec 30, 2024 | 26.74B | -22.58% |
| Dec 28, 2023 | 34.53B | -27.07% |
| Dec 29, 2022 | 47.35B | -62.21% |
| Dec 30, 2021 | 125.32B | -42.07% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biodyne | 375.03B |
| M.I.TECH Co.,Ltd | 222.34B |
| Synergy Innovation | 191.19B |
| BIOBIJOU | 124.42B |
| Corentec | 76.59B |
| DENTIS CO.,Ltd | 62.84B |
| Finemedix | 36.66B |
| Genolution | 32.99B |